Leiomyosarcoma Clinical Trials in Los Angeles, CA

Leiomyosarcoma Clinical Trials in Los Angeles, CA

View the best 10 leiomyosarcoma medical studies in Los Angeles, California. Access promising new therapies by applying to a Los Angeles-based Leiomyosarcoma clinical trial.

Top rated leiomyosarcoma clinical trials in Los Angeles, California

Here are the top 7 medical studies for leiomyosarcoma in Los Angeles, California

Image of Sarcoma Oncology Center in Los Angeles, United States.

Doxorubicin +1 More

Anti-tumor antibiotic

Recruiting1 awardPhase 2 & 3
This trial will test if a combo of two chemo drugs can prolong progression-free survival in those with metastatic leiomyosarcoma.
Image of Sarcoma Oncology Research Center in Santa Monica, United States.

Unesbulin +1 More

Chemotherapy

Recruiting0 awardsPhase 2 & 3
This trial will compare two different treatments for leiomyosarcoma, a type of cancer. One treatment will be the standard of care, and the other will be a new treatment that includes a drug called unesbulin. The trial will look at whether the new treatment is more effective and has fewer side effects than the standard treatment.
Image of Children's Hospital of Orange County (Pediatrics [up to 25 years old]) in Orange, United States.

Tabelecleucel

Virus Therapy

Recruiting1 awardPhase 2
This trial will test a new treatment for diseases caused by the Epstein-Barr virus.
Image of Mayo Clinic Arizona in Phoenix, United States.

Anlotinib +1 More

Tyrosine Kinase Inhibitor

Recruiting1 awardPhase 3
This trial is currently recruiting patients with alveolar soft part sarcoma only and is no longer recruiting patients with synovial sarcoma or leiomyosarcoma.
Image of Stanford Cancer Center in Stanford, United States.

Nanatinostat +2 More

HDAC inhibitor

Recruiting1 awardPhase 1 & 2
This trial will test if nanatinostat, in combination with valganciclovir or pembrolizumab, is safe and effective in treating patients with relapsed/refractory EBV-positive solid tumors or recurrent/metastatic nasopharyngeal carcinoma.
Image of Sant P Chawla in Santa Monica, United States.

Trabectedin

Alkylating agents

Recruiting3 awardsPhase 2
This trial is testing a new combination of drugs to treat cancer. The drugs are given at lower doses than usual, and more often.
Image of City of Hope Medical Center in Duarte, United States.

Cabozantinib +1 More

Tyrosine Kinase Inhibitor

Recruiting1 awardPhase 2
This trial is studying how well cabozantinib and temozolomide work in treating patients with leiomyosarcoma or other soft tissue sarcoma.

Popular filter options for leiomyosarcoma los-angeles trials

Clinical Trials With No Placebo

View 12 medical studies that do not have a placebo group.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.